Navigation Links
Revolutionary Therapy: Needle-Free Technology for the Treatment Of Blinding Eye Disease
Date:6/19/2008

SAN DIEGO, June 19 /PRNewswire/ -- Sydney company, Seagull Technology Pty Ltd, has developed a non-invasive drug delivery device that reduces the risks associated with the treatment of Australia's leading cause of blindness and severe vision loss -- Age Related Macular Degeneration (AMD), a degenerative disease of the retina which affects one in seven people over the age of 50. The technology uses a special gel and ultrasound (sound waves) in a handheld device to send drugs through the outer layers of the eye and into the damaged retina at the back of the eye. It is painless, quick and can be done safely in the doctors' consulting rooms rather than in a hospital or surgery.

(Photo: http://www.newscom.com/cgi-bin/prnh/20080619/AQTH066)

Because of a worldwide ageing population, AMD is one of the fastest growing forms of blindness and the potential market for the device is huge, according to company Executive Director, Dr Shanny Dyer.

Currently AMD treatment can require needle injections of drugs into the back of the eye which may cause patient fear, discomfort and carries a risk of further eye damage through complications associated with the injection rather than the drugs themselves.

The NSW Minister for Science and Medical Research Hon. Verity Firth, will launch the technology at the world's biggest biotechnology convention, BIO 2008, in San Diego. Image available at http://www.australiabio2008.com/SeagullNMR.php

Age Related Macular Degeneration (AMD) is a disease of the macula, the central part of the retina, and can result in loss of ability to read, drive, watch television or recognize faces.

AMD is the most common cause of vision loss in the developed world for those over 50 years of age. There are over 200,000 cases in the US and over 20,000 in Australia of people with the "wet" form of the disease, which currently is the only treatable form of AMD and requires the injection of drugs directly into the eye. The market is conservatively estimated at over $200 million annually in the US alone.

Other retinal damage caused by Diabetes related eye disease can also benefit from the device and available treatments.

Media Contacts

Susan Fitzpatrick

susan@datelinemedia.com

In San Diego Cell: 650 279 7771

Tania Ewing

In Australia Cell: 0408378422

taniaewing@healthinbox.com

Sydney office: +1 612 9006 1614

US office: 650 798 5238


'/>"/>
SOURCE Seagull Technology Pty Ltd
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Edge Health Solutions Releases edgeDMS(TM) 2.0 and edgeMD 2.0(TM), Revolutionary All-in-One Practice Management Software with FDA-Approved Advanced Visualization
2. New Thomson Reuters Biomarkers Report Shines a Light on Revolutionary New Area of Drug Development
3. Accuri Cytometers Announces Commercial Launch of Revolutionary Accuri C6 Flow Cytometer(TM) System
4. Revolutionary New Technique Uses Onyx to Fill Hard-To-Treat Aneurysms
5. ReBuilder Medical Technologies, Inc. Announces Revolutionary Electronic Zapper Said to Destroy Molluscum Contagiosum Pathogen
6. First Responders Acquire Revolutionary MyClyns(TM) Protective Spray
7. ILC Dover Launches Revolutionary ArmorFlex (R) Pharmaceutical Product Contact Film
8. 10th Anniversary of Revolutionary Teaching Approach that Offers the Severely Disabled the Gift of Self-Expression - Through Painting
9. Precedent Launches Revolutionary Individual Health Insurance Plans in Texas
10. Revolutionary HD Surgical Footage from North Shore-LIJ Surgeon to be Broadcast for the First Time on ABCs 20/20, National Geographic Channel
11. Keeping Kids Healthy and Fit: The New York Kids Club Launches a Revolutionary New Fitness Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... ... ... Dr. Ronald E. Hawkins, vice president for academic affairs ... Bell, DO, MBA, HPF, FACOEP-dist., FACEP, as the new dean of Liberty ... to Liberty from the Ohio University Heritage College of Osteopathic Medicine (OU-HCOM), where ...
(Date:2/24/2017)... ... February 24, 2017 , ... The narrative in “ Signal 8: ... ’s true account of his paramedic experiences. Schanssema describes the tragedies he saw, as ... attempts to overcome them. , Schanssema, initially unsure of the career path he wanted ...
(Date:2/24/2017)... ... , ... Indiana Fiber Network (IFN) President and CEO Kelly C. Dyer recently ... as the Chairman of the Management Committee when IFN was originally formed in 2002 ... of investor/owners and development of the business plan. He became the first paid ...
(Date:2/23/2017)... ... February 23, 2017 , ... Thinksport, the most ... Jensie Gran Fondo of Marin. For the second year in a row, cyclists ... sunscreen. , “We are thrilled to provide our safe, non-toxic sunscreen to over ...
(Date:2/23/2017)... ... February 23, 2017 , ... The American Cleft Palate-Craniofacial Association (ACPA) is pleased ... KLS is a longtime supporter of the event. , "We are pleased that KLS ... Dr. Bob Havlik, 2017 ACPA President. "KLS Martin has a long track record of ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... Feb. 24, 2017 Zimmer Biomet Holdings, Inc. ... healthcare, will present at the Cowen and Company 37 ... Marriott Copley Place on Tuesday, March 7, 2017 at ... webcast of the presentation can be accessed at ... following the conference via Zimmer Biomet,s Investor Relations website ...
(Date:2/24/2017)... , Feb. 24, 2017  In conjunction with ... 2016 financial results press release, you are invited to ... live over the internet on Tuesday, March 14, 2017 ... A live audio webcast of the presentation ... www.durect.com and clicking "Investor Relations."  If you are ...
(Date:2/24/2017)... 24. Februar 2017 ITL Limited, ( ... Gesundheitsbereiches, ist erfreut, für das zum 31. Dezember ... Vorjahreszeitraum exzellente Ergebnisse vorlegen zu können. Eine vollständige ... Wachstum" finden Sie hier . ... Steuern 2,12 Millionen USD (Dez. 2015: 1,04 Millionen USD; +104 %) ...
Breaking Medicine Technology: